Not trying to be negative but this doesnt sound to good...
The Norplant label describes the nature and frequency of adverse events related to
insertion and/or removals as follows:
Removal difficulties affecting subjects (based on 849 removals): 6.2%
Pain or itching near implant site (usually transient): 3.7%
Infection at the implant site: 0.7%
With respect to literature, one comprehensive review5 on adverse events from clinical
trials for Norplant and other implantable progestins is summarized below:
Removal complications occurred in up to 14.8% of users, mostly due to fibrous
pericapsular sheath formation around the implant or due to implant breakage, deep
placement or migration. In 0.8% of users, the procedure required a second incision or
was not successful, i.e. not all the implanted rods could be removed.
Removal complications in comparative studies between Norplant and Jadelle (two
rods) were 6.9% for Jadelle and 14.8% for Norplant, respectively.
Removal complications in comparative studies between Norplant and Implanon
(single rod), were 0.2% for Implanon and 4.8% for Norplant, respectively.
Infection rates with Norplant insertion in most studies were less than 0.5%, but two
studies reported infection rates 1% or greater. Most infections occurred within the
first two months (65%), but infections have been reported two years after insertion.
Most the side effects that are bothersome are less than 1% and even then aren't considered serious life threatening reactions. Implanon is a sub dermal device in use so these delivery systems aren't foreign or unheard or. Place your bets boys! I knew this would go down today but no way did I dream this much! Bought 80K shares at 1.21. I consider those to be never expiring options. Risk vs reward is very favorable in this situation, unless of course you took a beating today. In that case I'd either average down or pray for the best.
Big gains a coming! I can hear the cash registers, cha Ching cha Ching, with this one...